Gankyrin has a potential role in embryo implantation via activation of STAT3
article
OA: bronze
CC0
⤵ 1 in-corpus citation
AI-generated summary
Gankyrin expression increases during mid-secretory phase and promotes embryo implantation via STAT3 activation and MMP2 expression, as demonstrated in vitro and in vivo.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Embryo implantation, a critical step during the mammalian reproductive process, requires normal developing blastocysts and a receptive endometrium. Endometriosis, a common pathologically benign gynecological condition, is associated with decreased fertility and reduced endometrial receptivity. The oncoprotein, Gankyrin, has been associated with endometriosis and endometrial cancer. Here, we examined the role of Gankyrin during the process of embryo implantation and found that Gankyrin expression levels were significantly increased during the mid-secretory phase, but unaffected during the proliferative phase in the human endometrium. Using an in vitro cell adhesion assay to examine the cell adhesion rate of BeWo trophoblast spheroids to Gankyrin knockdown or overexpressing human endometrial carcinoma RL95-2 cells, we demonstrated that the adhesion rate was significantly reduced in Gankyrin-knockdown RL95-2 cells, while overexpression of Gankyrin promoted cell adhesion. Furthermore, we found that the downregulation of Gankyrin inhibited STAT3 activation and subsequent matrix metalloproteinase 2 (MMP2) expression, while overexpression led to STAT3 activation and MMP2 expression. In vivo, we found that Gankyrin expression was increased in the endometrium after conception but decreased with the prolongation of gestation time in female mice. siRNA-mediated knockdown of Gankyrin in the uterine horn led to a significant reduction in the number of implanted embryos 9 days post-gestation, which was associated with a decrease in p-STAT3 expression and MMP2 transcription. Taken together, our findings indicate that Gankryin has a potential role in embryo implantation via STAT3 activation.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- Endometriosis: pathogenesis and treatment 2013
- 异常在位子宫内膜是内异症的病因吗?-在位内膜在内异症发病中的作用 2011
- Decreased Endometrial IL-10 Impairs Endometrial Receptivity by Downregulating HOXA10 Expression in Women with Adenomyosis 2018
- The co-expression of GPER and Gankyrin in ovarian endometriosis and its correlation with the rASRM stages 2015
Cited by (1)
References (42)
- Decreased Endometrial IL-10 Impairs Endometrial Receptivity by Downregulating HOXA10 Expression in Women with Adenomyosis via openalex
- Endometriosis: pathogenesis and treatment via openalex
- The co-expression of GPER and Gankyrin in ovarian endometriosis and its correlation with the rASRM stages via openalex
- 异常在位子宫内膜是内异症的病因吗?-在位内膜在内异症发病中的作用 via openalex
- W1980487076 via openalex
- W1983416011 via openalex
- W1987912870 via openalex
- W1990498979 via openalex
- W2003143423 via openalex
- W2003673719 via openalex
- W2018621705 via openalex
- W2020204387 via openalex
- W2020390414 via openalex
- W2041390166 via openalex
- W2044724701 via openalex
- W2072503088 via openalex
- W2093775195 via openalex
- W2095003166 via openalex
- W2115435274 via openalex
- W2119975890 via openalex
- W2125571326 via openalex
- W2129299914 via openalex
- W2133192035 via openalex
- W2171875732 via openalex
- W2319571985 via openalex
- W2401206178 via openalex
- W2465751869 via openalex
- W2563535135 via openalex
- W2564119591 via openalex
- W2584153715 via openalex
- W2745118608 via openalex
- W2763764277 via openalex
- W2978921805 via openalex
- W3005858986 via openalex
- W3011139590 via openalex
- W3033214241 via openalex
- W3083298421 via openalex
- W3123832986 via openalex
- W4288400169 via openalex
- W1578810612 via openalex
- W1612799591 via openalex
- W1965311504 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-18T06:15:08.409253+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:24:03.506079+00:00
License: CC0
· commercial use OK